 |
 |

Lack of Information in Naltrexone Study—Reply
Sandra D. Comer, PhD;
Maria A. Sullivan, MD, PhD;
Elmer Yu, MD;
Jami L. Rothenberg, PhD;
Herbert D. Kleber, MD;
Kyle Kampman, MD;
Charles Dackis, MD;
Charles P. OBrien, MD
 |
 |
| Since this article does not have an abstract, we have provided the first 124 words of the full text and any section headings. |
|
 |
 |
In reply
In response to Dr Rastegar, here is the flow diagram (Figure) showing the number of patients assessed for eligibility and the number excluded from our study1 of injectable, sustained-release naltrexone for the treatment of opioid dependence.
Figure appears in full text version.
|
|
|
|
Figure. Flow diagram for study of injectable, sustained-release naltrexone for the treatment of opioid dependence. ITT indicates intention to treat.
|
|
|
AUTHOR INFORMATION
Correspondence: Dr Comer, The New York State Psychiatric Institute and College of Physicians and Surgeons of Columbia University, 1051 Riverside Dr, Unit 120, New York, NY 10032 (sdc10@columbia.edu).
Financial Disclosure: None reported.
1. Comer SD, Sullivan MA, Yu E, Rothenberg JL, Kleber HD, Kampman K, Dackis C, OBrien CP. Injectable, sustained-release naltrexone for the treatment of opioid dependence. Arch Gen Psychiatry. 2006;63(2):210-218.
FREE FULL TEXT
Arch Gen Psychiatry. 2007;64(7):865.
RELATED LETTER
Lack of Information in Naltrexone Study
Darius A. Rastegar
Arch Gen Psychiatry. 2007;64(7):865.
EXTRACT
| FULL TEXT
RELATED ARTICLE
Injectable, Sustained-Release Naltrexone for the Treatment of Opioid Dependence: A Randomized, Placebo-Controlled Trial
Sandra D. Comer, Maria A. Sullivan, Elmer Yu, Jami L. Rothenberg, Herbert D. Kleber, Kyle Kampman, Charles Dackis, and Charles P. OBrien
Arch Gen Psychiatry. 2006;63(2):210-218.
ABSTRACT
| FULL TEXT
|